abstract |
The present invention relates to an α-1A receptor partial agonist represented by the formula (I), and a pharmaceutically acceptable salt or solvate thereof. The invention further relates to pharmaceutical compositions containing the formula (I), methods for their use as therapeutic agents, and methods for their production. |